Full Length Research Paper
References
Aghokeng AF, Mpoudi-Ngole E, Dimodi H, Atem-Tambe A, Tongo M, Butel C, Delaporte E, Peeters M (2009). Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One 4(11):e7702. |
|
CDC, WHO, APL (2001). Guidelines for Appropriate Evaluations of HIV Testing Technologies in Africa. |
|
Charpentier C, Gody JC, Mbitikon O, Moussa S, Matta M, Péré H, Fournier J, Longo JDD, Bélec L (2012). Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. AIDS Research and Human Retroviruses 28:87-94. |
|
Cohen J (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement 20:37-46. |
|
Collectif BioBayes (2015). Initiation à la statistique bayésienne: bases théoriques et qpplications en qlimentation, environnement, épidémiologie et génétique. Edition Ellipses Paris, 360P. |
|
Comité Français d'accréditation. (2015). Guide de vérification (portee A) /validation (portee B) des méthodes en Biologie Médicale: Document SH GTA 04 Révision 01. 191p. |
|
Gody JC, Charpentier C, Mbitikon O, Si-Mohamed A, LeGoff J, Gresenguet G, Bélec L (2008). High prevalence of antiretroviral drug resistance mutations in HIV-1 Non-B Subtype strains from african children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations. Journal of Acquired Immune Deficiency Syndromes 49(5):566-569. |
|
Keen P, Conway DP, Cunningham P, McNulty A, Couldwell DL, Davies SC, Smith DE, Gray J, Holt M, O'Connor CC, Read P, Callander D, Prestage G, Guy R (2017). Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays. Journal of Clinical Virology 86:46-51. |
|
Klarkowski D, Glass K, O'Brien D, Lokuge K, Piriou E, Shanks L (2013). Variation in specificity of HIV rapid diagnostic tests over place and time: An analysis of discordancy data using a Bayesian approach. PLoS One 8(11):e81656. |
|
Klarkowski D, O'Brien DP, Shanks L, Singh KP (2014). Causes of false-positive HIV rapid diagnostic test results. Expert Review of Anti-infective Therapy 12:49-62. |
|
Kroidl I, Clowes P, Mwalongo W, Maganga L, Maboko L, Kroidl AL, Geldmacher C, Machibya H, Hoelscher M, Saathoff E (2012). Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania. PLoS One 7(6):e39529. |
|
Landis JR, Koch GG. (1977). The measurement of observer agreement for categorical data. Biometrics 33(1):159-174. |
|
Mbopi-Keou FX, Ndjoyi-Mbiguino A, Talla F, Péré H, Kebe K, Matta M, Sosso MA, Bélec L (2014). Association of inconclusive sera for human immunodeficiency virus infection with malaria and Epstein-Barr virus infection in Central Africa. Journal of Clinical Microbiology 52(2):660-662. |
|
Ménard D, Maïro A, Mandeng MJ, Doyemet P, Koyazegbe TA, Rochigneux C, Talarmin A (2005). Evaluation of rapid HIV testing strategies in under equipped laboratories in the Central African Republic. Journal of Virological Methods 126(1-2):75-80. |
|
Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Mbitikon O, Jenabian MA, Robin L, Matta M, Zeitouni K, Longom JDD, Costiniuk C, Grésenguet G, Touré Kane NC, Bélec L (2017). High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic. Medicine (Baltimore) 96:10. |
|
Mossoro-Kpindé CD, Jenabian MA, Gody JC, Robin L, Talla P, Longo JDD, Grésenguet G, Belec L (2016). Evaluation of the Upgraded Version 2.0 of the Roche COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Assay in Central African Children. The Open AIDS Journal10:158-163. |
|
ONUSIDA (2020). Data sheet 2020-Latest statistics on the state of the AIDS epidemic. |
|
UNAIDS (2015). Understand fast track accelerating section to end the AIDS epidemic by 2030. |
|
UNAIDS (2019). Central African Republic Data sheet. |
|
UNITAID, WHO (2018). HIV rapid diagnostic tests for self-testing. 4th edition. Market and technology landscape. |
|
World Health Organization (WHO) (2016). Human immunodeficiency virus (HIV) rapid diagnostic tests for professional use and/or self-testing-TSS-1. |
|
World Health Organization (WHO) (2017). Technical Specifications Series for submission to WHO Prequalification-Diagnostic Assessment: Human immunodeficiency virus (HIV) rapid diagnostic tests for professional use and/or self-testing. Geneva: World Health Organization. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0